← All organizations
Highest phase reached
Phase 3
First clinical trial
Jul 1, 1996Last known activity
Aug 1, 2013
Timeline
No events for the selected filters.
Drugs by trial phase (10 distinct, 3 trials)
Phase 3 (5 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (6)
- NCT02272738Study directorPhase 1Aug 1, 2013
- NCT02272738Lead sponsorPhase 1Aug 1, 2013
- NCT01430052Lead sponsorPhase 2Apr 1, 2009
- NCT01430052Reponsible party - principal investigatorPhase 2Apr 1, 2009
- NCT01430052Study directorPhase 2Apr 1, 2009
- NCT00152178Overall official - principal investigatorPhase 3Jul 1, 1996
Details
- Last known activity
- Aug 1, 2013